176 related articles for article (PubMed ID: 35849191)
1. Methotrexate induced neurotoxicity in a patient with rheumatoid arthritis on rituximab therapy: a case-based review.
Kougkas N; Dara A; Pagkopoulou E; Dimitriadou A; Papadimitriou E; Avdelidou E; Garyfallos A; Dimitroulas T
Rheumatol Int; 2022 Oct; 42(10):1849-1854. PubMed ID: 35849191
[TBL] [Abstract][Full Text] [Related]
2. Leukoencephalopathy induced by low-dose methotrexate in a patient with rheumatoid arthritis.
Matsuda M; Kishida D; Kinoshita T; Hineno A; Shimojima Y; Fukushima K; Ikeda S
Intern Med; 2011; 50(19):2219-22. PubMed ID: 21963744
[TBL] [Abstract][Full Text] [Related]
3. Multifocal leukoencephalopathy in a patient medicated with etanercept and methotrexate for rheumatoid arthritis.
Yu T; Yang C
Z Rheumatol; 2024 May; 83(4):297-302. PubMed ID: 37755473
[TBL] [Abstract][Full Text] [Related]
4. Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial.
Wijesinghe H; Galappatthy P; de Silva R; Seneviratne SL; Saravanamuttu U; Udagama P; Hart M; Kelleher P; Senerath U; Fernandopulle R; Weerasekera LP; Wijayaratne LS
BMC Musculoskelet Disord; 2017 Jul; 18(1):310. PubMed ID: 28724365
[TBL] [Abstract][Full Text] [Related]
5. Real-world clinical experience of biological disease modifying anti-rheumatic drugs in Malaysia rheumatoid arthritis patients.
Tan BE; Lim AL; Kan SL; Lim CH; Tsang EEL; Ch'ng SS; Mohd Noor N; Mohd Jamid N; Teh CL; Joshua Thundyil R; Loh YL; Chong HC; Ong SG; Mohamed Ismail A; Lee YYL; Gun SC
Rheumatol Int; 2017 Oct; 37(10):1719-1725. PubMed ID: 28695274
[TBL] [Abstract][Full Text] [Related]
6. Update on methotrexate as the anchor drug for rheumatoid arthritis.
Pincus T; Gibson KA; Castrejón I
Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S9-19. PubMed ID: 24219036
[TBL] [Abstract][Full Text] [Related]
7. Leukoencephalopathy due to oral methotrexate.
González-Suárez I; Aguilar-Amat MJ; Trigueros M; Borobia AM; Cruz A; Arpa J
Cerebellum; 2014 Feb; 13(1):178-83. PubMed ID: 24068485
[TBL] [Abstract][Full Text] [Related]
8. Reversible leukoencephalopathy after oral methotrexate.
Koppen H; Wessels JA; Ewals JA; Treurniet FE
J Rheumatol; 2012 Sep; 39(9):1906-7. PubMed ID: 22942312
[No Abstract] [Full Text] [Related]
9. Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.
Singh JA; Hossain A; Tanjong Ghogomu E; Mudano AS; Maxwell LJ; Buchbinder R; Lopez-Olivo MA; Suarez-Almazor ME; Tugwell P; Wells GA
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012591. PubMed ID: 28282491
[TBL] [Abstract][Full Text] [Related]
10. Progressive multifocal leukoencephalopathy in autoimmune diseases.
Palazzo E; Yahia SA
Joint Bone Spine; 2012 Jul; 79(4):351-5. PubMed ID: 22281228
[TBL] [Abstract][Full Text] [Related]
11. Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT.
Brown S; Everett CC; Naraghi K; Davies C; Dawkins B; Hulme C; McCabe C; Pavitt S; Emery P; Sharples L; Buch MH
Health Technol Assess; 2018 Jun; 22(34):1-280. PubMed ID: 29900829
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
Müller RB; von Kempis J; Haile SR; Schiff MH
Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
[TBL] [Abstract][Full Text] [Related]
13. Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review.
Wang W; Zhou H; Liu L
Eur J Med Chem; 2018 Oct; 158():502-516. PubMed ID: 30243154
[TBL] [Abstract][Full Text] [Related]
14. Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugs.
Solomon DH; Kremer JM; Fisher M; Curtis JR; Furer V; Harrold LR; Hochberg MC; Reed G; Tsao P; Greenberg JD
Semin Arthritis Rheum; 2014 Feb; 43(4):489-97. PubMed ID: 24012043
[TBL] [Abstract][Full Text] [Related]
15. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Shea B; Swinden MV; Tanjong Ghogomu E; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
Cochrane Database Syst Rev; 2013 May; 2013(5):CD000951. PubMed ID: 23728635
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of an anti-CD20 monoclonal antibody (Reditux™) for the treatment of patients with moderate to severe rheumatoid arthritis following the failure of conventional synthetic disease-modifying anti-rheumatic drugs.
Bhati M; Bandyopadhyay S
Clin Rheumatol; 2016 Aug; 35(8):1931-1935. PubMed ID: 27334114
[TBL] [Abstract][Full Text] [Related]
17. Tofacitinib Versus Biologic Treatments in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Tumor Necrosis Factor Inhibitors: Results From a Network Meta-analysis.
Vieira MC; Zwillich SH; Jansen JP; Smiechowski B; Spurden D; Wallenstein GV
Clin Ther; 2016 Dec; 38(12):2628-2641.e5. PubMed ID: 27889300
[TBL] [Abstract][Full Text] [Related]
18. Optimizing Methotrexate Treatment in Rheumatoid Arthritis: The Case for Subcutaneous Methotrexate Prior to Biologics.
Sharma P; Scott DG
Drugs; 2015 Nov; 75(17):1953-6. PubMed ID: 26474779
[TBL] [Abstract][Full Text] [Related]
19. Effects of a biologic agent in a patient with rheumatoid arthritis after treatment for methotrexate-associated B-cell lymphoma: a case report.
Kuroda T; Sato H; Nakatsue T; Wada Y; Murakami S; Nakano M; Narita I
BMC Res Notes; 2014 Apr; 7():229. PubMed ID: 24721419
[TBL] [Abstract][Full Text] [Related]
20. Rituximab pharmacokinetics in patients with rheumatoid arthritis: B-cell levels do not correlate with clinical response.
Breedveld F; Agarwal S; Yin M; Ren S; Li NF; Shaw TM; Davies BE
J Clin Pharmacol; 2007 Sep; 47(9):1119-28. PubMed ID: 17766699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
